Submission for Review: Survey on the Treatment of Opioid Use Disorders; Correction, 71004-71005 [2019-27708]

Download as PDF 71004 Federal Register / Vol. 84, No. 247 / Thursday, December 26, 2019 / Notices copies of the information collection instrument(s) and instructions should be directed to Claire Little, NASA Clearance Officer, NASA Headquarters, 300 E Street SW, JF0000, Washington, DC 20546 or email claire.a.little@ nasa.gov. khammond on DSKJM1Z7X2PROD with NOTICES SUPPLEMENTARY INFORMATION: I. Abstract The Electronic Health Record System is used by the NASA Occupational Health Program to generate records of medical care, diagnosis, treatment, surveillance examinations (e.g., flight certification, special purpose and health maintenance), and exposure records (e.g., hazardous materials and ionizing radiation). Management and utilization of the Electronic Health Record System provides necessary supportive clerical services for the Occupational Health Program. Occupational Health clinics create, maintain and securely archive digital medical records and physical examination records of (1) NASA civil service employees and applicants; (2) other Agency civil service and military employees working at NASA; (3) active or retired astronauts and active astronaut family members; (4) International Space Partner personnel, their families, or other space flight personnel on temporary or extended duty at NASA; (5) onsite contractor personnel who receive job-related examinations under the NASA Occupational Health Program, have work-related mishaps or accidents, or visit clinics for emergency or first-aid treatment; and (6) visitors to NASA Centers who use clinics for emergency or first-aid treatment or who apply for use of NASA facilities. The legal medical record is the documentation of health care services provided to an individual; it is used for clinical decision making, following accurate recording of observations, actions and analysis of diagnostic tests. The legal medical record in this instance is digital recorded data collected and used for providing healthcare at the NASA Occupational Health clinics. Additionally, the medical record is used as a tool for evaluating the adequacy, appropriateness and quality of care. Such records contain standard clinical information resulting from physical examinations, laboratory and other relevant diagnostic tests, and medical history surveys; screening examination results; immunization records; administration of medications prescribed by private/personal or NASA physicians; consultation records; and hazardous exposure as well as other health hazard/abatement data. VerDate Sep<11>2014 16:53 Dec 23, 2019 Jkt 250001 NASA collects, archives, and secures information from individuals visiting the Occupational Health clinics requiring routine medical examination in compliance with the following regulations: • 2015 Joint Commission (JC) Standards for Ambulatory Care IM.01.01.01, IM.02.01.03, IM.02.02.01, IM.02.02.03 • NASA Procedural Requirements, NPR 1800.1C. • NASA Records Retention Schedules NRRS 1441.1 • 5 U.S.C. 552a, Privacy Act, 1974 • 42 U.S.C. 2472; 44 U.S.C. 3101; Public Law 92–255 • NIST SP 800–53 revision 4, Recommended Security Controls for Federal Information Systems • NIST SP 800–53A, Techniques and Procedures for Verifying the Effectiveness of Security Controls in Federal Information Systems • NPR 2810.1, Security of Information Technology. II. Methods of Collection Electronically and optionally by paper. III. Data Title: NASA Electronic Health Record System (EHRS). OMB Number: 2700–xxxx. Type of review: New. Affected Public: Individuals. Estimated Annual Number of Activities: 63,260. Estimated Number of Respondents per Activity: 1. Annual Responses: 63,260. Estimated Time per Response: 0.5 hours. Estimated Total Annual Burden Hours: 31,630. Estimated Total Annual Cost: $819,217.00. IV. Request for Comments Comments are invited on: (1) Whether the proposed collection of information is necessary for the proper performance of the functions of NASA, including whether the information collected has practical utility; (2) the accuracy of NASA’s estimate of the burden (including hours and cost) of the proposed collection of information; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including automated collection techniques or the use of other forms of information technology. Comments submitted in response to this notice will be summarized and included in the request for OMB approval of this information collection. PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 They will also become a matter of public record. Cheryl Parker, NASA Federal Liaison Officer. [FR Doc. 2019–27776 Filed 12–23–19; 8:45 am] BILLING CODE 7510–13–P EXECUTIVE OFFICE OF THE PRESIDENT Office of National Drug Control Policy Submission for Review: Survey on the Treatment of Opioid Use Disorders; Correction Office of National Drug Control Policy, Executive Office of the President. AGENCY: 30-Day notice and request for comments; correction. ACTION: The Office of National Drug Control Policy published a document in the Federal Register on December 12, 2019 concerning the Paperwork Reduction Act; Proposed Collection; Comment Request. The document contained an incorrect address and contact information. SUMMARY: SUPPLEMENTARY INFORMATION: Correction In the Federal Register of December 12, 2019 84 FR 67963, correct the ADDRESSES caption to read: Interested persons are invited to submit written comments on the proposed information collection to the Office of Information and Regulatory Affairs, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503, Attention: Desk Officer for the Office of National Drug Control Policy or sent via electronic mail to oira_submission@omb.eop.gov or faxed to (202) 395–6974. ADDRESSES: Correction In the Federal Register of December 12, 2019 84 FR 67963, correct the FOR FURTHER INFORMATION CONTACT caption to read: A copy of this ICR, with applicable supporting documentation, may be obtained by contacting the Office of Information and Regulatory Affairs, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503, Attention: Desk Officer for the Office of National Drug Control Policy or sent via electronic mail oira_submission@ omb.eop.gov or faxed to (202) 395–6974. FOR FURTHER INFORMATION CONTACT: E:\FR\FM\26DEN1.SGM 26DEN1 Federal Register / Vol. 84, No. 247 / Thursday, December 26, 2019 / Notices Dated: December 18, 2019. Michael Passante, Acting General Counsel. NUCLEAR REGULATORY COMMISSION [NRC–2019–0158] [FR Doc. 2019–27708 Filed 12–23–19; 8:45 am] BILLING CODE 3280–F5–P EXECUTIVE OFFICE OF THE PRESIDENT Office of National Drug Control Policy Submission for Review: Survey on Practices and Policies Related to the Treatment of Opioid Use Disorders; Correction Office of National Drug Control Policy. ACTION: 30-Day Notice and request for comments; correction The Office of National Drug Control Policy published a document in the Federal Register on December 12, 2019 concerning the Paperwork Reduction Act; Proposed Collection; Comment Request. The document contained an incorrect address and contact information. SUPPLEMENTARY INFORMATION: SUMMARY: Correction In the Federal Register of December 12, 2019 84 FR 67964, correct the ADDRESSES caption to read: ADDRESSES: Interested persons are invited to submit written comments on the proposed information collection to the Office of Information and Regulatory Affairs, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503, Attention: Desk Officer for the Office of National Drug Control Policy or sent via electronic mail to oira_submission@omb.eop.gov or faxed to (202) 395–6974. khammond on DSKJM1Z7X2PROD with NOTICES Correction In the Federal Register of December 12, 2019 84 FR 67964, correct the FOR FURTHER INFORMATION caption to read: FOR FURTHER INFORMATION CONTACT: A copy of this ICR, with applicable supporting documentation, may be obtained by contacting the Office of Information and Regulatory Affairs, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503, Attention: Desk Officer for the Office of National Drug Control Policy or sent via electronic mail oira_submission@ omb.eop.gov or faxed to (202) 395–6974. [FR Doc. 2019–27709 Filed 12–23–19; 8:45 am] BILLING CODE 3280–F5–P VerDate Sep<11>2014 16:53 Dec 23, 2019 Jkt 250001 Nuclear Regulatory Commission. ACTION: Notice of submission to the Office of Management and Budget; request for comment. AGENCY: AGENCY: Dated: December 18, 2019. Michael Passante, Acting General Counsel. Information Collection: NRC Form 327, Special Nuclear Material and Source Material Physical Inventory Summary Reports, and NUREG/BR–0096, Instructions and Guidance for Completing Physical Inventory Summary Reports The U.S. Nuclear Regulatory Commission (NRC) has recently submitted a request for renewal of an existing collection of information to the Office of Management and Budget (OMB) for review. The information collection is entitled, ‘‘NRC Form 327, Special Nuclear Material and Source Material Physical Inventory Summary Reports, and NUREG/BR–0096, Instructions and Guidance for Completing Physical Inventory Summary Reports.’’ DATES: Submit comments by January 27, 2020. Comments received after this date will be considered if it is practical to do so, but the Commission is able to ensure consideration only for comments received on or before this date. ADDRESSES: Submit comments directly to the OMB reviewer at: OMB Office of Information and Regulatory Affairs (3150–0139), Attn: Desk Officer for the Nuclear Regulatory Commission, 725 17th Street, NW Washington, DC 20503; email: oira_submission@omb.eop.gov. FOR FURTHER INFORMATION CONTACT: David Cullison, NRC Clearance Officer, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; telephone: 301–415–2084; email: INFOCOLLECTS.Resource@nrc.gov. SUPPLEMENTARY INFORMATION: SUMMARY: I. Obtaining Information and Submitting Comments A. Obtaining Information Please refer to Docket ID NRC–2019– 0158 when contacting the NRC about the availability of information for this action. You may obtain publiclyavailable information related to this action by any of the following methods: • Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC–2019–0158. A copy of the collection of information and related instructions may be obtained without charge by accessing Docket ID NRC–2019–0158 on this website. PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 71005 • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publiclyavailable documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301– 415–4737, or by email to pdr.resource@ nrc.gov. A copy of the collection of information and related instructions may be obtained without charge by accessing ADAMS Accession ML19161A296 and ML082620258. The supporting statement is available in ADAMS under Accession No. ML19318C417. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. • NRC’s Clearance Officer: A copy of the collection of information and related instructions may be obtained without charge by contacting the NRC’s Clearance Officer, David Cullison, Office of the Chief Information Officer, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; telephone: 301–415–2084; email: INFOCOLLECTS.Resource@NRC.GOV. B. Submitting Comments The NRC cautions you not to include identifying or contact information in comment submissions that you do not want to be publicly disclosed in your comment submission. All comment submissions are posted at https:// www.regulations.gov and entered into ADAMS. Comment submissions are not routinely edited to remove identifying or contact information. If you are requesting or aggregating comments from other persons for submission to the OMB, then you should inform those persons not to include identifying or contact information that they do not want to be publicly disclosed in their comment submission. Your request should state that comment submissions are not routinely edited to remove such information before making the comment submissions available to the public or entering the comment into ADAMS. II. Background Under the provisions of the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35), the NRC recently submitted a request for renewal of an existing collection of information to OMB for review entitled, ‘‘NRC Form 327, Special Nuclear Material and E:\FR\FM\26DEN1.SGM 26DEN1

Agencies

[Federal Register Volume 84, Number 247 (Thursday, December 26, 2019)]
[Notices]
[Pages 71004-71005]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-27708]


=======================================================================
-----------------------------------------------------------------------

EXECUTIVE OFFICE OF THE PRESIDENT

Office of National Drug Control Policy


Submission for Review: Survey on the Treatment of Opioid Use 
Disorders; Correction

AGENCY: Office of National Drug Control Policy, Executive Office of the 
President.

ACTION: 30-Day notice and request for comments; correction.

-----------------------------------------------------------------------

SUMMARY: The Office of National Drug Control Policy published a 
document in the Federal Register on December 12, 2019 concerning the 
Paperwork Reduction Act; Proposed Collection; Comment Request. The 
document contained an incorrect address and contact information.

SUPPLEMENTARY INFORMATION: 

Correction

    In the Federal Register of December 12, 2019 84 FR 67963, correct 
the Addresses caption to read:

ADDRESSES: Interested persons are invited to submit written comments on 
the proposed information collection to the Office of Information and 
Regulatory Affairs, Office of Management and Budget, 725 17th Street 
NW, Washington, DC 20503, Attention: Desk Officer for the Office of 
National Drug Control Policy or sent via electronic mail to 
[email protected] or faxed to (202) 395-6974.

Correction

    In the Federal Register of December 12, 2019 84 FR 67963, correct 
the For Further Information Contact caption to read:

FOR FURTHER INFORMATION CONTACT: A copy of this ICR, with applicable 
supporting documentation, may be obtained by contacting the Office of 
Information and Regulatory Affairs, Office of Management and Budget, 
725 17th Street NW, Washington, DC 20503, Attention: Desk Officer for 
the Office of National Drug Control Policy or sent via electronic mail 
[email protected] or faxed to (202) 395-6974.


[[Page 71005]]


    Dated: December 18, 2019.
Michael Passante,
Acting General Counsel.
[FR Doc. 2019-27708 Filed 12-23-19; 8:45 am]
 BILLING CODE 3280-F5-P